Making decisions about benefits and harms of medicines
- PMID: 15231628
- PMCID: PMC443458
- DOI: 10.1136/bmj.329.7456.47
Making decisions about benefits and harms of medicines
Abstract
Even when good scientific data are available, people's interpretation of risks and benefits will differ
Figures


Comment in
-
Balancing benefits and harms in health care: ethical dimension was not discussed in theme issue.BMJ. 2004 Aug 21;329(7463):458; discussion 458-9. doi: 10.1136/bmj.329.7463.458. BMJ. 2004. PMID: 15321912 Free PMC article. No abstract available.
Comment on
-
Detection, verification, and quantification of adverse drug reactions.BMJ. 2004 Jul 3;329(7456):44-7. doi: 10.1136/bmj.329.7456.44. BMJ. 2004. PMID: 15231627 Free PMC article. Review.
Similar articles
-
Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.Drug Saf. 2011 Mar 1;34(3):187-97. doi: 10.2165/11586620-000000000-00000. Drug Saf. 2011. PMID: 21332243 Review.
-
Strategy in Regulatory Decision-Making for Management of Progressive Multifocal Leukoencephalopathy.Clin Pharmacol Ther. 2015 Nov;98(5):502-5. doi: 10.1002/cpt.199. Epub 2015 Sep 11. Clin Pharmacol Ther. 2015. PMID: 26250806 Review.
-
Good decision making requires good communication.Drug Saf. 2012 Nov 1;35(11):983-93. doi: 10.1007/BF03261986. Drug Saf. 2012. PMID: 23061776
-
Primum non nocere.JAMA. 1977 Aug 15;238(7):589-90. JAMA. 1977. PMID: 577959 No abstract available.
-
Improving the Safety of Medicines in the European Union: From Signals to Action.Clin Pharmacol Ther. 2020 Mar;107(3):521-529. doi: 10.1002/cpt.1678. Epub 2019 Dec 6. Clin Pharmacol Ther. 2020. PMID: 31621897 Free PMC article. Review.
Cited by
-
Adverse drug reactions in drug information databases: does presentation affect interpretation?J Med Libr Assoc. 2020 Jan;108(1):76-83. doi: 10.5195/jmla.2020.748. Epub 2020 Jan 1. J Med Libr Assoc. 2020. PMID: 31897054 Free PMC article.
-
Is There a Tension between Clinical Practice and Reimbursement Policy? The Case of Osteoarthritis Prescribing Practices in Ontario.Healthc Policy. 2007 Nov;3(2):e128-44. Healthc Policy. 2007. PMID: 19305773 Free PMC article.
-
Evaluation of adverse drug reaction formatting in drug information mobile phone applications.J Med Libr Assoc. 2022 Jan 1;110(1):81-86. doi: 10.5195/jmla.2022.1251. J Med Libr Assoc. 2022. PMID: 35210966 Free PMC article.
-
Pharmacokinetics and Perceptions of Children and Young Adults Using Cannabis for Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder: Protocol for a Mixed Methods Proof-of-Concept Study.JMIR Res Protoc. 2021 Oct 18;10(10):e31281. doi: 10.2196/31281. JMIR Res Protoc. 2021. PMID: 34661540 Free PMC article.
-
Social Media and COVID-19-Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics.Antibiotics (Basel). 2022 Mar 25;11(4):445. doi: 10.3390/antibiotics11040445. Antibiotics (Basel). 2022. PMID: 35453198 Free PMC article.
References
-
- Bastani B, Alphs LD, Meltzer HY. Development of the clozaril patient management system. Psychopharmacology (Berl) 1989;99(suppl): S122-5. - PubMed
-
- Mayer EA, Bradesi S. Alosetron and irritable bowel syndrome. Expert Opin Pharmacother 2003;4: 2089-98. - PubMed
-
- Ances BM. New concerns about thalidomide. Obstet Gynecol 2002;99: 125-8. - PubMed
-
- Berwick DM. The total customer relationship in health care: broadening the bandwidth. Joint Commission Journal on Quality Improvement 1997;23: 245-50. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical